{"id":422506,"date":"2019-08-23T23:26:01","date_gmt":"2019-08-23T23:26:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=422506"},"modified":"2019-08-23T23:26:01","modified_gmt":"2019-08-23T23:26:01","slug":"intravenous-solution-market-to-show-a-769-of-cagr-till-2023-icu-medical-inc-us-b-braun-melsungen-ag-germany-fresenius-kabi-ag-germany-etc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/intravenous-solution-market-to-show-a-769-of-cagr-till-2023-icu-medical-inc-us-b-braun-melsungen-ag-germany-fresenius-kabi-ag-germany-etc_422506.html","title":{"rendered":"Intravenous Solution Market to Show a 7.69% of CAGR till 2023 | ICU Medical, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), etc"},"content":{"rendered":"
\"Intravenous<\/a><\/p>\n
\n
Intravenous Solution Market<\/div>\n<\/div>\n<\/div>\n
Intravenous Solution Market Report is added on MarketResearchFuture.com with Worldwide Segmentation, geological regions and Top companies. Detail analysis on possible segments and sub segments of the market.<\/p>\n<\/div>\n

Intravenous Solution Market Global Players:<\/strong><\/p>\n

ICU Medical, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain) and others.<\/p>\n

Intravenous Solution Market Global Overview:<\/strong><\/p>\n

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration.  There are various type of IV solutions available for use in the market. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022.<\/p>\n

Request Free Sample Copy at  <\/strong>https:\/\/www.marketresearchfuture.com\/sample_request\/1235<\/a> .<\/p>\n

Segmentation:<\/strong><\/p>\n

Global IV Solutions Market has been segmented on the basis of types which comprises of Peripheral Parenteral Nutrition and Total Parenteral Nutrition. On the basis of nutritional content which comprises of Amino acid solution, Carbohydrates, Vitamins & minerals, parenteral lipid emulsion and others. On the basis of end users the global IV solutions market includes Hospital & Clinics, Ambulatory and Home Care.<\/em><\/p>\n

Regional Analysis:<\/strong><\/p>\n


<\/strong>The global market for IV Solutions is growing steadily. The market for IV Solutions is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 6,543.4 million by 2022. This is attributed to the factors such as Growing acceptance of vitamin C intravenous for Colorectal Cancer and increasing prevalence of the chronic diseases. Europe is the second largest market which is growing at a CAGR of 8.12% from 2016-2022.  Asia-Pacific region is the fastest growing market for IV Solutions, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022.<\/p>\n

Key Finding:<\/strong><\/p>\n